Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Impact of Nicotinamide Mononucleotide Sustained-release Tablets on Immunosenescence and Metablism in Middle-aged and Elderly Individuals With Metabolic Disorders.
Sponsor: Qing Su
Summary
The ageing of our country is increasing and the ageing of the population has led to a significant increase in aging related diseases. During the aging process of the organism, cellular senescence can occur in all systems of the body, of which the senescence of the immune system is called immunosenescence. Some studies have shown that metabolic disorders can also trigger aging. This study investigated the effect of nicotinamide mononucleotide (NMN) supplementation on immunosenescence in middle-aged and elderly people through a placebo-controlled long-range clinical trail, aiming to provide a new method to improve immunosenescence. The effects of NMN supplementation on glucose and lipid metabolic indexes, body composition and telomere length of peripheral blood cells are also investigated, which may open up new ideas for the prevention and treatment of glucose and lipid metabolic diseases.
Key Details
Gender
All
Age Range
50 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
126
Start Date
2025-06-05
Completion Date
2027-03-31
Last Updated
2025-07-08
Healthy Volunteers
No
Conditions
Interventions
NMN
NMN SR tablets(1000mg/tablets) , 1 tablet daily before breakfast
Placebo
Matching Placebo (tablets) once daily before breakfast
Locations (1)
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, China